| Style | Citing Format |
|---|---|
| MLA | Karimi E, et al.. "Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review." Immunity, Inflammation and Disease, vol. 14, no. 3, 2026, pp. -. |
| APA | Karimi E, Moradi Z, Soroureddin S, Nouri O, Tamartash Z, Kavosi H (2026). Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review. Immunity, Inflammation and Disease, 14(3), -. |
| Chicago | Karimi E, Moradi Z, Soroureddin S, Nouri O, Tamartash Z, Kavosi H. "Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review." Immunity, Inflammation and Disease 14, no. 3 (2026): -. |
| Harvard | Karimi E et al. (2026) 'Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review', Immunity, Inflammation and Disease, 14(3), pp. -. |
| Vancouver | Karimi E, Moradi Z, Soroureddin S, Nouri O, Tamartash Z, Kavosi H. Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review. Immunity, Inflammation and Disease. 2026;14(3):-. |
| BibTex | @article{ author = {Karimi E and Moradi Z and Soroureddin S and Nouri O and Tamartash Z and Kavosi H}, title = {Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review}, journal = {Immunity, Inflammation and Disease}, volume = {14}, number = {3}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Karimi E AU - Moradi Z AU - Soroureddin S AU - Nouri O AU - Tamartash Z AU - Kavosi H TI - Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review JO - Immunity, Inflammation and Disease VL - 14 IS - 3 SP - EP - PY - 2026 ER - |